The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema
Public ClinicalTrials.gov record NCT02050828. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Active-Controlled, Double-Masked, Multi-Center Study to Assess the Safety and Efficacy of Daily Subcutaneous AKB-9778 Administered for 3 Months, as Monotherapy or Adjunctive to Ranibizumab, in Subjects With Diabetic Macular Edema
Study identification
- NCT ID
- NCT02050828
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aerpio Therapeutics
- Industry
- Enrollment
- 144 participants
Conditions and interventions
Conditions
Interventions
- AKB-9778 Drug
- ranibizumab Drug
- Placebo Drug
- Sham Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2013
- Primary completion
- Mar 31, 2015
- Completion
- Apr 30, 2015
- Last update posted
- Mar 15, 2017
2014 – 2015
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Pheonix | Arizona | 85014 | — |
| Not listed | Pheonix | Arizona | 85020 | — |
| Not listed | Tucson | Arizona | 85704 | — |
| Not listed | Arcadia | California | 91007 | — |
| Not listed | Bakersfield | California | 93309 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Palm Desert | California | 92260 | — |
| Not listed | Sacramento | California | 95819 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Santa Barbara | California | 93103 | — |
| Not listed | Golden | Colorado | 80401 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Fort Lauderdale | Florida | 33334 | — |
| Not listed | Fort Myers | Florida | 33912 | — |
| Not listed | Miami | Florida | 33126 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | Stuart | Florida | 34994 | — |
| Not listed | Winter Haven | Florida | 33880 | — |
| Not listed | Baltimore | Maryland | 21287 | — |
| Not listed | Jackson | Michigan | 49202 | — |
| Not listed | Omaha | Nebraska | 68198 | — |
| Not listed | Reno | Nevada | 89502 | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | Charlotte | North Carolina | 28210 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Florence | South Carolina | 29501 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Abilene | Texas | 79606 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Fort Worth | Texas | 76102 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | McAllen | Texas | 78503 | — |
| Not listed | San Antonio | Texas | 78240 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Warrenton | Virginia | 20186 | — |
| Not listed | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02050828, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02050828 live on ClinicalTrials.gov.